205 related articles for article (PubMed ID: 38172585)
1. Using the photon isoeffective dose formalism to compare and combine BNCT and CIRT in a head and neck tumour.
Postuma I; Magni C; Marcaccio B; Fatemi S; Vercesi V; Ciocca M; Magro G; Orlandi E; Vischioni B; Ronchi S; Liu YH; Han Y; Geng C; González SJ; Bortolussi S
Sci Rep; 2024 Jan; 14(1):418. PubMed ID: 38172585
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Photon Isoeffective Dose Models Based on In Vitro and In Vivo Radiobiological Experiments for Head and Neck Cancer Treated with BNCT.
Perotti Bernardini GF; Bortolussi S; Koivunoro H; Provenzano L; Ferrari C; Cansolino L; Postuma I; Carando DG; Kankaanranta L; Joensuu H; González SJ
Radiat Res; 2022 Aug; 198(2):134-144. PubMed ID: 35504003
[TBL] [Abstract][Full Text] [Related]
3. Photon iso-effective dose for cancer treatment with mixed field radiation based on dose-response assessment from human and an animal model: clinical application to boron neutron capture therapy for head and neck cancer.
González SJ; Pozzi ECC; Monti Hughes A; Provenzano L; Koivunoro H; Carando DG; Thorp SI; Casal MR; Bortolussi S; Trivillin VA; Garabalino MA; Curotto P; Heber EM; Santa Cruz GA; Kankaanranta L; Joensuu H; Schwint AE
Phys Med Biol; 2017 Oct; 62(20):7938-7958. PubMed ID: 28858854
[TBL] [Abstract][Full Text] [Related]
4. Combined BNCT-CIRT treatment planning for glioblastoma using the effect-based optimization.
Han Y; Geng C; Altieri S; Bortolussi S; Liu Y; Wahl N; Tang X
Phys Med Biol; 2023 Dec; 69(1):. PubMed ID: 38048635
[No Abstract] [Full Text] [Related]
5. Understanding the potentiality of accelerator based-boron neutron capture therapy for osteosarcoma: dosimetry assessment based on the reported clinical experience.
Bortolussi S; Postuma I; Protti N; Provenzano L; Ferrari C; Cansolino L; Dionigi P; Galasso O; Gasparini G; Altieri S; Miyatake SI; González SJ
Radiat Oncol; 2017 Aug; 12(1):130. PubMed ID: 28806981
[TBL] [Abstract][Full Text] [Related]
6. Exploring Boron Neutron Capture Therapy for non-small cell lung cancer.
Farías RO; Bortolussi S; Menéndez PR; González SJ
Phys Med; 2014 Dec; 30(8):888-97. PubMed ID: 25176019
[TBL] [Abstract][Full Text] [Related]
7. Triple ionization chamber method for clinical dose monitoring with a Be-covered Li BNCT field.
Nguyen TT; Kajimoto T; Tanaka K; Nguyen CC; Endo S
Med Phys; 2016 Nov; 43(11):6049. PubMed ID: 27806584
[TBL] [Abstract][Full Text] [Related]
8. Detailed dosimetry calculation for in-vitro experiments and its impact on clinical BNCT.
Viegas AMD; Postuma I; Bortolussi S; Guidi C; Riback JS; Provenzano L; Marcaccio B; Rossini AE; Ferrari C; Cansolino L; Ferrari M; Portu AM; González SJ
Phys Med; 2021 Sep; 89():282-292. PubMed ID: 34474326
[TBL] [Abstract][Full Text] [Related]
9. A Model for Estimating Dose-Rate Effects on Cell-Killing of Human Melanoma after Boron Neutron Capture Therapy.
Matsuya Y; Fukunaga H; Omura M; Date H
Cells; 2020 Apr; 9(5):. PubMed ID: 32365916
[TBL] [Abstract][Full Text] [Related]
10. On the eptihermal neutron energy limit for Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT): Study and impact of new energy limits.
Hervé M; Sauzet N; Santos D
Phys Med; 2021 Aug; 88():148-157. PubMed ID: 34265549
[TBL] [Abstract][Full Text] [Related]
11. Monte Carlo based protocol for cell survival and tumour control probability in BNCT.
Ye SJ
Phys Med Biol; 1999 Feb; 44(2):447-61. PubMed ID: 10070794
[TBL] [Abstract][Full Text] [Related]
12. DEPTH DISTRIBUTIONS OF RBE-WEIGHTED DOSE and PHOTON-ISOEFFECTIVE DOSE FOR BORON NEUTRON CAPTURE THERAPY.
Sato T; Masunaga SI; Kumada H; Hamada N
Radiat Prot Dosimetry; 2019 May; 183(1-2):247-250. PubMed ID: 30535354
[TBL] [Abstract][Full Text] [Related]
13. Advantage and limitations of weighting factors and weighted dose quantities and their units in boron neutron capture therapy.
Rassow J; Sauerwein W; Wittig A; Bourhis-Martin E; Hideghéty K; Moss R
Med Phys; 2004 May; 31(5):1128-34. PubMed ID: 15191301
[TBL] [Abstract][Full Text] [Related]
14. On-line reconstruction of low boron concentrations by in vivo gamma-ray spectroscopy for BNCT.
Verbakel WF; Stecher-Rasmussen F
Phys Med Biol; 2001 Mar; 46(3):687-701. PubMed ID: 11277217
[TBL] [Abstract][Full Text] [Related]
15. Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer.
Barth RF; Vicente MG; Harling OK; Kiger WS; Riley KJ; Binns PJ; Wagner FM; Suzuki M; Aihara T; Kato I; Kawabata S
Radiat Oncol; 2012 Aug; 7():146. PubMed ID: 22929110
[TBL] [Abstract][Full Text] [Related]
16. The photon-isoeffective dose in boron neutron capture therapy.
González SJ; Santa Cruz GA
Radiat Res; 2012 Dec; 178(6):609-21. PubMed ID: 23148506
[TBL] [Abstract][Full Text] [Related]
17. Influence of Neutron Sources and 10B Concentration on Boron Neutron Capture Therapy for Shallow and Deeper Non-small Cell Lung Cancer.
Yu H; Tang X; Shu D; Liu Y; Geng C; Gong C; Hang S; Chen D
Health Phys; 2017 Mar; 112(3):258-265. PubMed ID: 28121726
[TBL] [Abstract][Full Text] [Related]
18. Importance of radiobiological studies for the advancement of boron neutron capture therapy (BNCT).
Monti Hughes A
Expert Rev Mol Med; 2022 Mar; 24():e14. PubMed ID: 35357286
[TBL] [Abstract][Full Text] [Related]
19. Out-of-field dosimetry using a validated PHITS model and computational phantom in clinical BNCT.
Kakino R; Hu N; Tanaka H; Takeno S; Aihara T; Nihei K; Ono K
Med Phys; 2024 Feb; 51(2):1351-1363. PubMed ID: 38153111
[TBL] [Abstract][Full Text] [Related]
20. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
